You were had, so you bet we're f'ing done. Read and weep,

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks copytele #117958
188
You were had, so you bet we're f'ing done. Read and weep, that is If you can comprehend it and admit you screwed up.

Bayer executive’s comments misinterpreted in social media posts

By Reuters Fact Check

https://www.reuters.com/article/idUSL1N2YF1AI/

June 28, 20229:22 AM CDTUpdated 2 years ago

Remarks by Bayer executive Stefan Oelrich in 2021 have been shared on social media to spread the false allegation that COVID-19 mRNA vaccines are a form of gene therapy.


Contrary to claims online, Oelrich was highlighting the public’s acceptance of such technological innovation as an example of how people could potentially also accept the company’s gene and cell therapies.

“The CEO of Bayer basically stating that 95% of people wouldn’t have taken the mRna 'gene therapy' two years ago. People were TRICKED and intentionally LIED TO, which was why so many people did,” reads a tweet with the 41-seconds-long clip ( here ).

An iteration on Instagram stating Oelirich admitted “that the COVID-19 vaccine is in fact gene therapy,” has garnered at least 4,475 likes. ( here )
Other iterations can be found ( here )( here ) ( here )
THE CLIP

The clip dates from Oct. 24, 2021, during the opening ceremony of the World Health Summit 2021. The commentary highlighted online can be heard around timestamp 1:37:27 ( here ).

But Oelrich, member of Bayer AG’s Board of Management and head of the Pharmaceuticals Division ( here ), did not “admit” the mRNA shots are a form of gene therapy as claimed on social media.

Further context shows that he was instead speaking about how the acceptance of a biotech innovation like mRNA COVID-19 vaccines was an example of how cell and gene therapies, another biotech innovation, could be received by the public.

“And for us therefore, we are really taking that leap -- us as a company Bayer -- in cell and gene therapy, which to me is one of these examples, where we are really going to make a difference, hopefully, moving forward.”

“Ultimately the mRNA vaccines are an example for that cell and gene therapy. I always like to say, if we had surveyed two years ago in the public, ‘would you be willing to take gene or cell therapy and inject it into your body?,’ we would have probably had a 95% refusal rate. I think this pandemic has also opened many people’s eyes to innovation in the way that was maybe not possible before.”

Moments earlier, Oelrich discussed innovation in the biotech field. “We’ve seen the vaccines as the perfect example during this crisis, but innovations in the field of biotech also radically up-end our view on many other diseases, specially NCDs ( here ). We can now think of curing many of those diseases, not just treating symptoms as we think forward.” ( youtu.be/OJFKBritLlc?t=5771 )

Reuters has reported about the German company’s efforts on developing cell and gene therapy ( here ) ( here ).

THE SCIENCE

Reuters previously addressed false claims that mRNA COVID-19 vaccines are a form of gene therapy ( here) or that the vaccines alter the recipient’s DNA (here) (here) (here)

While mRNA vaccines by Pfizer/BioNTech and Moderna can be considered a genetic-based therapy, because they use genetic material, a piece of RNA based on SARS-CoV-2, to prompt an immune response in recipients (here), this is not the same as gene therapy, which is designed to permanently change
the body’s genetic makeup, experts have told Reuters.

“Gene therapy, in the classical sense, involves making deliberate changes to a patient’s DNA in order to treat or cure them. mRNA vaccines will not enter a cell’s nucleus that houses your DNA genome. There is zero risk of these vaccines integrating into our own genome or altering our genetic makeup,” Dr Adam Taylor, a virologist and research fellow at the Menzies Health Institute, Queensland, Griffith University, told Reuters in August 2021.

Unlike gene therapy (here) (here), mRNA vaccines are then “rapidly degraded” by the body, Taylor said.

More information about gene therapy and mRNA vaccines can be found (here) (here).

VERDICT

False. In this clip, Bayer executive Stefan Oelrich did not “admit” that mRNA COVID-19 vaccines are “in fact” gene therapy. He was highlighting the public’s acceptance of a technological innovation like mRNA COVID-19 vaccines as an example of how people could potentially also accept the company’s gene and cell therapies.

While mRNA vaccines do use genetic material, they are not designed to change the recipient’s genetic makeup and thus they are distinct from gene therapy.

This article was produced by the Reuters Fact Check team. Read more about our fact-checking work here .
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Mighty 25: Celebrating Military Community Leaders

Updated Category News Views 4

A Spotlight on Unsung Heroes Tampa, Florida, just got a little mightier as We Are The Mighty rolls out the red carpet for the 2026 Mighty 25. This annual roll call, backed by CareSource Military & Veterans™, shines a light on veterans, military spouses, creators, entrepreneurs, and change agents defying the status quo. They are redefining impact across the military...

Continue Reading
ECARX Leverages AI for Next-Gen Auto Intelligence

Updated Category News Views 2

ECARX's Latest Ventures in AI-Driven Mobility ECARX is making waves with its recent announcement to integrate Tencent Cloud's WorkBuddy AI with the Flyme AIOS operating system. It's not a small tweak; it's a big leap forward in pushing AI boundaries in automobiles. If you're looking at ECARX Holdings Inc. (Nasdaq: ECX) as an investment, here's the meat and potatoes of...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 1

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
Skyven's Heat Pump Sets New Steam Efficiency Benchmark

Updated Category News Views 2

The Efficiency Game-Changer in Industrial Steam Swinging in like a seasoned market shake-up is Skyven Technologies, raising eyebrows—and interest—by nailing a coefficient of performance (COP) of 8.0 for their Arcturus heat pump. You don't have to be a market wizard to know that's a big leap from the initial COP of 6.5. It's more than just numbers on a page; this...

Continue Reading
SCO at 25: China's Strategic Push for Regional Growth

Updated Category News Views 6

There's a new beat coming out of Central Asia, and it's resonating all the way from China's boardrooms to the barren landscapes of the Gobi Desert. With the Shanghai Cooperation Organization (SCO) celebrating its 25th anniversary, we're witnessing a pivot from a security-centric setup to a full-blown economic collaboration machine. The Landscape of SCO's Evolution Look,...

Continue Reading
Opus Group Revamps Turkish Vehicle Inspection System

Updated Category News Views 0

Leveraging Expertise in Vehicle Inspection Opus Group is gearing up to revolutionize the vehicle inspection landscape in Türkiye. With a staggering 34.5 million vehicles on the roads, and an annual inspection quota hitting 16 million, the market is ripe for innovation. The U.S.-based Opus Group, a giant in the realm of vehicle inspection programs with about 30 million...

Continue Reading
Nexio's New Campus Ignites Truck Production Ambitions

Updated Category News Views 6

Big Moves into the Big Truck Arena Nexio Power is making significant strides in making heavy trucks powered by propane a reality. By securing a massive 77-acre campus in Anderson, Texas, the company is setting the stage for immediate production capabilities. It's not often you see a company like Nexio pulling the rug out from others so quietly but effectively. This campus...

Continue Reading
Adecoagro Expands with Caarapó Mill Acquisition

Updated Category News Views 1

Crushing the Competition: Adecoagro's New Acquisition When there's dirt under your fingernails and deals in the air, taking a strategic swing like Adecoagro just did can be a game-changer. Shelling out R$705 million (roughly US$136 million) in cash isn't what you'd call pocket change, but they're not new to ballsy moves. They've snapped up the Caarapó Mill, previously...

Continue Reading
Sceye's Stratospheric Leap: A Revolution in Connectivity

Updated Category News Views 2

Sceye's Game-Changer: Stratospheric Connectivity Breakthrough Every once in a while, a tech leap makes folks sit up straight. Maybe it's the allure of a new gadget or a mind-blowing application that spells out change in big, bold letters. Well, Sceye just lobbed one over the Pacific that's like a stone-cold revolution in the world of connectivity. Imagine a game of chess...

Continue Reading
Indico Breach May Expose Thousands to Identity Theft

Updated Category News Views 3

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Intelligent Bio Solutions Awards Stock to Executives Amid Growth

Updated Category News Views 126

Intelligent Bio Solutions Inc. (NASDAQ: INBS) recently made waves by awarding fully vested shares to its top executives, a move that raised eyebrows in the trading community. CEO Harry Simeonidis pocketed 40,000 shares valued at around $76,400 while CFO Spiro Sakiris got 34,500 shares worth approximately $65,895 based on the company's stock closing price from September...

Continue Reading
JPMorgan Chase Launches Innovative Solo 401(k) for Entrepreneurs

Updated Category News Views 295

JPMorgan Chase Introduces Solo 401(k) for Entrepreneurs In an exciting development for solo entrepreneurs and self-employed individuals, JPMorgan Chase has launched the Solo 401(k), an innovative retirement solution crafted specifically for those without full-time employees. This addition represents a significant advancement in their Everyday 401(k) program, reaffirming...

Continue Reading
UNHCR-TECNO Partnership Boosts Refugee Education

Updated Category News Views 6

A Year in: UNHCR-TECNO's Bold Move to Educate Refugees Sometimes you gotta marvel at human tenacity. Take TECNO and UNHCR's mission to deliver educational progress for refugees in East Africa. A year deep, they're crafting real change—not just spewing noble aims loaded with platitudes. We're talking classrooms constructed, not just blueprints stashed away in some dusty...

Continue Reading
Katten Partners Recognized Among Top Experts in Crypto Sector

Updated Category News Views 169

Katten Partners Shine in Crypto Industry Recognition Katten, a well-respected law firm, has gained significant attention for its leadership in the evolving digital asset landscape. Three of its distinguished partners have been recognized by Citywealth, a leading publication in the private wealth sector, for their exceptional contributions to the cryptocurrency domain. The...

Continue Reading
loanDepot Welcomes Alec Hanson as Senior VP of Production

Updated Category News Views 142

loanDepot's New Leadership in Production loanDepot, Inc. (NYSE: LDI) has appointed Alec Hanson as the Senior Vice President of Production for its West division. This strategic move is a part of loanDepot's efforts to enhance its retail sales leadership team, which includes industry veterans like Paul Ramos and Mary Bane, who lead the Southeast/Mid-Atlantic and...

Continue Reading